Schedule 13G/A (Amendment No. 1)

0001193125-17-043362.txt : 20170214 0001193125-17-043362.hdr.sgml : 20170214 20170214160717 ACCESSION NUMBER: 0001193125-17-043362 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 GROUP MEMBERS: FORBION I MANAGEMENT B.V. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88012 FILM NUMBER: 17608661 BUSINESS ADDRESS: STREET 1: MEIBERGDREFF 61 CITY: AMSTERDAM STATE: P7 ZIP: 1005 BA BUSINESS PHONE: 31-20-5667394 MAIL ADDRESS: STREET 1: MEIBERGDREFF 61 CITY: AMSTERDAM STATE: P7 ZIP: 1005 BA FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Forbion Co-Investment Cooperatief U.A. CENTRAL INDEX KEY: 0001634138 IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PO BOX 5187, 1410 AD CITY: NAARDEN STATE: P8 ZIP: 00000 BUSINESS PHONE: 31 0 35 699 3019 MAIL ADDRESS: STREET 1: PO BOX 5187, 1410 AD CITY: NAARDEN STATE: P8 ZIP: 00000 SC 13G/A 1 d348864dsc13ga.htm SCHEDULE 13G/A (AMENDMENT NO. 1) Schedule 13G/A (Amendment No. 1)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

uniQure N.V.

(Name of Issuer)

Common Stock, par value EUR 0.05 per share

(Title of Class of Securities)

N90064101

(CUSIP Number)

31 DECEMBER 2016

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 90064101		13G		Page 2 of 6 Pages


1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Forbion Co-Investment Coöperatief U.A.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION The Netherlands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.	SOLE VOTING POWER 0
		6.	SHARED VOTING POWER 1,530,501
		7.	SOLE DISPOSITIVE POWER 0
		8.	SHARED DISPOSITIVE POWER 1,530,501
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,530,501
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.29% 1
12.	TYPE OF REPORTING PERSON OO

1	The foregoing percentage is calculated based on the 24,327,944 Ordinary Shares outstanding as of December 31, 2015 as reported in the Issuer’s Form 20-F filed with the Securities and Exchange Commission (the “ Commission”) on April 13, 2016


CUSIP No. 90064101		13G		Page 3 of 6 Pages


1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Forbion I Management B.V.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION The Netherlands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.	SOLE VOTING POWER 0
		6.	SHARED VOTING POWER 1,530,501
		7.	SOLE DISPOSITIVE POWER 0
		8.	SHARED DISPOSITIVE POWER 1,530,501
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,530,501
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.29% 2
12.	TYPE OF REPORTING PERSON OO

2	The foregoing percentage is calculated based on the 24,327,944 Ordinary Shares outstanding as of December 31, 2015 as reported in the Issuer’s Form 20-F filed with the Securities and Exchange Commission (the “ Commission”) on April 13, 2016


CUSIP No. 90064101		13G		Page 4 of 6 Pages

Item 1(a).

Name of Issuer:

uniQure N.V.

Item 1(b).

Address of Issuer’s Principal Executive Offices:

Meibergdreef 61, 1105BA Amsterdam, The Netherlands

Item 2(a).

Name of Person Filing:

This Statement is being filed by Forbion Co-Investment Coöperatief U.A. (“Co-Invest COOP”), and Forbion 1 Management B.V. (“Forbion”), the director of Co-Invest COOP. Co-Invest COOP and Forbion are sometimes referred to collectively herein as the “Reporting Persons”.

Item 2(b).

Address of Principal Business Office or, if None, Residence:

The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Co-Investment Coöperatief U.A., PO Box 5187, 1410 AD Naarden, The Netherlands.

Item 2(c).

Citizenship:

Forbion Co-Investment Coöperatief U.A. – The Netherlands

Forbion 1 Management B.V. – The Netherlands

Item 2(d).

Title of Class of Securities:

common stock, par value $0.05 per share

Item 2(e).

CUSIP Number:

N90064101

Item 3.

Item 4.

Ownership.

Co-Invest COOP is the beneficial owner of 1,530,501 shares of Common Stock as of December 31, 2016 (the “Shares”). Forbion, the director of Co-Invest COOP, has voting and investment power over the shares held by Co-Invest COOP, which are exercised through Forbion’s investment committee, consisting of H. A. Slootweg, M. A. van Osch, G. J. Mulder and S. J. H. van Deventer. None of the members of the investment committee have individual voting and investment power with respect to such shares, and the members disclaim beneficial ownership of such shares except to the extent of their proportionate pecuniary interests therein

(a)

Amount beneficially owned: 1,530,501

(b)

Percent of class: 6.29%


CUSIP No. 90064101		13G		Page 5 of 6 Pages

The foregoing percentage is calculated based on the 24,327,944 Ordinary Shares outstanding as of December 31, 2015 as reported in the Issuer’s Form 20-F filed with the Securities and Exchange Commission (the “ Commission”) on April 13, 2016.

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 1,530,501

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 1,530,501

Item 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

The Reporting Persons are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Reporting Persons disclaim membership in a group and this report shall not be deemed an admission by any of the Reporting Persons that they are or may be members of a “group” for purposes of Rule 13d-5 or for any other purpose.

Item 9.

Notice of Dissolution of Group.

Not applicable

Item 10.

Certification.

Not applicable


CUSIP No. 90064101		13G		Page 6 of 6 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2017


FORBION CO-INVESTMENT COÖPERATIEF U.A. By its Director FORBION 1 MANAGEMENT B.V.

By:		/s/ M.A. van Osch /s/ H.A. Slootweg
		Name: M.A. van Osch H.A. Slootweg
		Title: its Directors